Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2003

View Archived Issues

Spotlight on F-13640, a 5-HT1A receptor agonist for the treatment of neuropathic pain

NW-1029 inhibits Na+ currents in rat sensory neurons

NO-releasing paracetamol derivative NCX-701 reduces pain-related behavior in nerve-injured rats

Antihyperalgesic effects of cizolirtine in diabetic rats via adenosine A1 and CCK2 receptors

PJ-34, a PARP inhibitor, reverses early diabetic neuropathy in rats

New antitumor, antibacterial and antifungal agents from Penicillium sp.

Pfizer presents novel PDE4 inhibitors and their use

Novel cathepsin K inhibitors under study at Aventis

Neurocrine patent covers series of pyrrole-based melanocortin receptor modulators

KCNQ potassium channel openers identified by ICAgen researchers

GSK patent describes new vanilloid VR1 antagonists, their preparation and use

Serostim E.U. appeal results in second negative opinion

Incyte and Pharmasset enter Reverset licensing agreement

New phase II trial evaluates MDX-010 for metastatic breast cancer

Second phase III trial of SPI-0211 for constipation completes enrollment

Taisho ends anti-CD23 collaboration

Long-term phase I/II data support use of I2S for Hunter's syndrome

Teva submits rasagiline NDA for Parkinson's disease

Completion of phase I Aurexis study

SBIR grant supports StemCells' spinal cord injury work

New siRNA agents demonstrate inhibition of SARS virus

Pregabalin safe and effective in postherpetic neuralgia and fibromyalgia syndrome

Everolimus alleviates cardiac vasculopathy after heart transplant

Discovery and SAR of a series of sulfonamides as JNK inhibitors reported by Serono

J&J presents new series of histamine H3 antagonists with biological activity

Boehringer Ingelheim presents data on new HCV NS5B RNA-dependent RNA polymerase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...